Honorary Clinical Associate Professor Jim Faed

2024

Journal - Research Other

Badami, K. G., & Faed, J. M. (2024). Warfarin reversal in patients with antiphospholipid syndrome: Caution required, but clear guidance not available. British Journal of Haematology. Advance online publication. doi: 10.1111/bjh.19816

2023

Other Research Output

Faed, J. (2023, April). The 21^st century iron renaissance: A new Iron Age has started. Otago Medical School Alumni Association (OMSAA) History of Medicine and Science Talks, Dunedin, New Zealand. Retrieved from https://www.youtube.com/watch?v=PcLz5BkAaL8

2020

Journal - Research Article

Zhang, J., Crimmins, D., Faed, J. M., Flanagan, P., McGhee, C. N. J., & Patel, D. V. (2020). Characteristics of platelet lysate compared to autologous and allogeneic serum eye drops. Translational Vision Science & Technology, 9(4), 24. doi: 10.1167/tvst.9.4.24

2018

Journal - Research Article

Ng, D. P. J., Duffull, S. B., Faed, J. M., Isbister, G. K., & Gulati, A. (2018). An evaluation of a factor Xa-based clotting time test for enoxaparin: A proof-of-concept study. Clinical & Applied Thrombosis/Hemostasis, 24(4), 669-676. doi: 10.1177/1076029617711802

Journal - Research Other

Kerr, N., Kerr, J., Faed, J. M., & Krysa, J. (2018). Spontaneous intracerebral haemorrhage: A rare complication of aortic aneurysm endoleak. BMJ Case Reports. doi: 10.1136/bcr-2018-225249

2017

Journal - Research Article

Nelson, V. J., Dinnunhan, M. F. K., Turner, P. R., Faed, J. M., & Cabral, J. D. (2017). A chitosan/dextran-based hydrogel as a delivery vehicle of human bone-marrow derived mesenchymal stem cells. Biomedical Materials, 12(3), 035012. doi: 10.1088/1748-605X/aa70f2

Muhsin-Sharafaldine, M.-R., Kennedy, B. R., Saunderson, S. C., Buchanan, C. R., Dunn, A. C., Faed, J. M., & McLellan, A. D. (2017). Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles. Biochimica et Biophysica Acta: General Subjects, 1861(2), 286-295. doi: 10.1016/j.bbagen.2016.11.020

2016

Journal - Research Article

Anderson, K. R., & Faed, J. M. (2016). Evaluation of particulate material in stored units of New Zealand re-suspended red cells. New Zealand Journal of Medical Laboratory Science, 70(3), 106-109.

Goldman, M., Magnussen, K., Gorlin, J., Lozano, M., Speedy, J., Keller, A., … Faed, J., … Klein, H. G. (2016). International Forum regarding practices related to donor haemoglobin and iron. Vox Sanguinis, 111(4), 449-455. doi: 10.1111/vox.12431

Muhsin-Sharafaldine, M.-R., Saunderson, S. C., Dunn, A. C., Faed, J. M., Kleffmann, T., & McLellan, A. D. (2016). Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. Oncotarget, 7(35), 56279-56294. doi: 10.18632/oncotarget.10783

Conference Contribution - Verbal presentation and other Conference outputs

Muhsin-Sharafaldine, M.-R., Saunderson, S. C., Dunn, A. C., Faed, J. M., Kleffmann, T., & McLellan, A. D. (2016, August-September). Procoagulant and immunogenic properties of tumour exosomes, microvesicles and apoptotic vesicles. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

Cabral, J. D., Nelson, V., Faed, J., Hanton, L., & Moratti, S. (2016, August-September). Development and characterization of chitosan/dextran-based hydrogels for adult stem cell delivery. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

2015

Journal - Research Article

Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2015). Application of adaptive DP-optimality to design a pilot study for a clotting time test for enoxaparin. Pharmaceutical Research, 32(10), 3391-3402. doi: 10.1007/s11095-015-1715-1

Wong, W.-W., MacKenzie, A. D., Nelson, V. J., Faed, J. M., & Turner, P. R. (2015). Octanoate in human albumin preparations is detrimental to mesenchymal stromal cell culture. Stem Cells International, 2015, 192576. doi: 10.1155/2015/192576

Aung, N. N., Kennedy, H., Faed, J. M., & Brennan, S. O. (2015). Novel heterozygous Bbeta (c.1311T>A) mutation (Fibrinogen St Kilda) associated with recurrent pregnancy loss. Pathology, 47(6), 583-585. doi: 10.1097/pat.0000000000000307

Conference Contribution - Poster Presentation (not in published proceedings)

Muhsin, M.-R., Dunn, A., Saunderson, S., Faed, J., & McLellan, A. (2015, October). The effects of tumour vesicles on cancer metastasis. Poster session presented at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.

2014

Journal - Research Article

Brennan, S. O., Mangos, H., & Faed, J. M. (2014). Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative y211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia. Thrombosis & Haemostasis, 111(4), 679-684. doi: 10.1160/TH13-08-0657

2013

Conference Contribution - Published proceedings: Abstract

Muhsin, M.-R., Saunderson, S., Black, L., Dunn, A., Faed, J., & McLellan, A. (2013). The effects of tumour vesicles on cancer progression. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 137-138). Retrieved from http://www.asi2013.org/

Faed, J. M. (2013). A systems approach to a Massive Transfusion Protocol (MTP). Transfusion, 53(Suppl. S2), (pp. 196A). doi: 10.1111/trf.12401

Yap, A., Faed, J., & Chiruka, S. (2013). An audit of outcomes for patients treated with Prothrombinex-VF. New Zealand Medical Journal, 126(1374). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Verbal presentation and other Conference outputs

Gunn, K., Faed, J., & Warner, M. (2013, November). Managing systems not problems. Verbal presentation at the New Zealand Anaesthesia (NZA) Annual Scientific Meeting, Dunedin, New Zealand.

2012

Journal - Research Article

Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2012). Development and evaluation of a prototype of a novel clotting time test to monitor enoxaparin. Pharmaceutical Research, 29(1), 225-235. doi: 10.1007/s11095-011-0537-z

Journal - Research Other

Duffull, S. B., Wright, D. F. B., Al-Sallami, H. S., Zufferey, P. J., & Faed, J. M. (2012). Dabigatran: Rational dose individualisation and monitoring guidance is needed. New Zealand Medical Journal, 125(1357). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2012). Evaluation of a clotting time test for enoxaparin: A pilot study. Proceedings of the Medical Sciences Congress (MedSci). (pp. 22). Retrieved from http://www.medscinz.co.nz/QRW2012%20MedSci%20Abstracts.pdf

Harper, P., Aung, N. N., Eaddy, N., Faed, J., May, S., Merriman, E., … Young, L. (2012). Dabigatran should be used with caution in the frail elderly: Lessons from New Zealand. American Journal of Hematology, 87(Suppl. 1), (pp. S175-S176). doi: 10.1002/ajh.23168

Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2012). Adaptive PD-optimal design of a pilot study for a clotting time test for enoxaparin. Proceedings of the 14th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://www.paganz.org/conference/melbourne-2012-14th-annual-scientific-meeting

2011

Conference Contribution - Published proceedings: Abstract

Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2011). Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity. Proceedings of the Twentieth Annual Meeting of the Population Approach Group in Europe. PAGE. Retrieved from http://www.page-meeting.org/?abstract=1967

Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2011). Identification and initial evaluation of a prototype clotting time test for enoxaparin. Proceedings of the Population Approach Group in Australia and New Zealand Meeting (PAGANZ). PAGANZ. Retrieved from http://www.paganz.org/default.asp?id=45&keuze=program

Conference Contribution - Verbal presentation and other Conference outputs

Gulati, A., Faed, J. M., Isbister, G. K., & Duffull, S. B. (2011, December). Identification and initial evaluation of a prototype clotting time test for enoxaparin. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), Australian Physiological Society (AuPS), High Blood Pressure Research Council of Australia (HBPRCA) Joint Meeting, Perth, Australia.

2010

Conference Contribution - Published proceedings: Abstract

Gulati, A., Faed, J., Isbister, G., & Duffull, S. B. (2010). Development and evaluation of a clotting time test for monitoring enoxaparin therapy. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting and the 6th Annual Carney Pharmacogenomics Symposium. ASCEPT. Retrieved from http://www.ascept.org.nz/

2009

Journal - Research Article

Harkins, C., Hammond-Tooke, G., & Faed, J. (2009). Intravenous immunoglobulin therapy for neurological disorders. New Zealand Medical Journal, 122(1305). Retrieved from http://journal.nzma.org.nz/journal/122-1305/3850/content.pdf

Conference Contribution - Published proceedings: Abstract

Badami, K., Kyle, P. M., Faed, J. M., Russell, G. A., Warrington, S. C., & Wall, L. D. (2009). Haemolytic disease of the fetus and newborn due to Anti-RH17-treatment with ABO-mismatched, Rhnull & CMV-positive transfusions. Transfusion. 49(Suppl.), (pp. 205A-206A). [Abstract]

2007

Journal - Research Article

Dear, A., Brennan, S. O., Sheat, M. J., Faed, J. M., & George, P. M. (2007). Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin λ light chain. Haematologica, 92, e111-e117. doi: 10.3324/haematol.11837

2002

Conference Contribution - Published proceedings: Abstract

Zacharias, M., Hodgson, B. F., & Faed, J. M. (2002). Bleeding in scoliosis surgery - a retrospective audit. New Zealand Orthopaedic Association Conference. 84(B), (pp. 272). Journal of Bone and Joint Surgery. [Abstract]

2001

Journal - Research Article

Ferguson, E. L., Morison, I. M., Faed, J. M., Parnell, W. R., McKenzie, J. E., Wilson, N. C., & Russell, D. G. (2001). Dietary iron intakes and biochemical iron status of 15-49 year old women in New Zealand: Is there a cause for concern? New Zealand Medical Journal, 114, 134-148.

2000

Journal - Research Article

Brennan, S. O., Fellowes, A. P., Faed, J. M., & George, P. M. (2000). Hypofibrinogenemia in an individual with two coding (γ82 Ala→Gly and β235 Pro→Leu) and two non-coding mutations. Blood, 95, 1709-1713.

Conference Contribution - Published proceedings: Abstract

Faed, J. M. (2000). Is a new approach needed to the female blood donor with low iron status? Vox Sanguinis. 78, (pp. P331). [Abstract]

Faed, J. M. (2000). A simple method for screening red cell and platelet units for bacteria. Vox Singuinis. 78. [Abstract]

1999

Authored Book - Research

Russell, D. G., Parnell, W. R., Wilson, N. C., Faed, J. M., Ferguson, E. L., Horwath, C. C., Herbison, G. P., Nye, E. R., Reid, P., Walker, R. J., Wilson, B. D., & Tukuitonga, C. (1999). NZ Food: NZ People. Key results of the 1997 National Nutrition Survey (LINZ® Activity & Health Research Unit). Wellington: Ministry of Health, 268p.

Journal - Research Article

Scrimshaw, B. J., Faed, J. M., Tate, W. P., & Yun, K. (1999). The frequency in New Zealand of a mitochondrial DNA mutation (1555 A to G) associated with aminoglycoside-induced hearing loss. New Zealand Medical Journal, 112, 216-217.

Scrimshaw, B. J., Faed, J. M., Tate, W. P., & Yun, K. (1999). Rapid identification of a 1555 A to G mutation in human mitochronical DNA implicated in aminoglycoside-induced ototoxicity. Journal of Human Genetics, 44, 388-390.

Conference Contribution - Published proceedings: Abstract

Skeaff, C. M., Nye, E. R., Faed, J. M., Mann, J. I., McKenzie, J. D., Parnell, W. R., Wilson, N. C., & Russell, D. G. (1999). Cholesterol status of the New Zealand population: Should we be concerned? Pacific Partners in Nutrition, 2nd South-West Pacific Nutrition & Dietetic Conference. Auckland, NZ. [Abstract]

Ferguson, E. L., Faed, J. M., Morison, I. M., McKenzie, J. D., Parnell, W. R., Wilson, N. C., & Russell, D. G. (1999). Iron status in New Zealand: Is there a public health concern? Pacific Partners in Nutrition, 2nd South-West Pacific Nutrition & Dietetic Conference. Auckland. [Abstract]

1998

Conference Contribution - Published proceedings: Abstract

Faed, J. M., Tan, G. H., Shew, M., Gouldie, P. J., & Williams, S. L. (1998). Optimisation of conditions for cryoprecipitation of fibrinogen. Transfusion suppl. 38, (pp. 76S). [Abstract]

1997

Journal - Research Article

Takeuchi, T., Soejima, H., Faed, J. M., & Yun, K. (1997). Efficient large-scale screening for the hemochromatosis susceptibility gene mutation. Blood, 90(7), 2848-2849.

Burt, M. J., Upton, J. D., Morison, I. M., Chapman, B. A., Faed, J. M., & George, P. M. (1997). Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis. New Zealand Medical Journal, 110(1056), 429-432.

Ridgeway, H. J., Brennan, S. O., Faed, J. M., & George, P. M. (1997). Fibrinogen Otago: A major α chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. British Journal of Haematology, 98(3), 632-639. doi: 10.1046/j.1365-2141.1997.2753090.x

Journal - Research Other

Soejima, H., Takeuchi, T., Gunn, J., Faed, J. M., & Yun, K. (1997). Rapid identification of a hemochromatosis susceptibility gene mutation. Trends in Genetics, Technical Tips Online, 2, 107-108. Retrieved from http://www.elsevier.com/locate/tto

Conference Contribution - Published proceedings: Full paper

Fitches, A., Hananeia, L., Faed, J. M., & Olds, R. J. (1997). Antithrombin locus genotype and plasma antithrombin activity. Thrombosis and Haemostasis. Supplement, (pp. 432). [Full Paper]

Conference Contribution - Published proceedings: Abstract

Faed, J. M. (1997). Particle release from blood donor packs: A new quality assurance test is needed. Transfusion suppl. 37, (pp. S145). [Abstract]

Faed, J. M. (1997). Successful management of pregnancy in a patient with severe dysfibrinogenaemia. Transfusion suppl. 38, (pp. 82). [Abstract]

1996

Conference Contribution - Published proceedings: Abstract

Ridgeway, H. J., Brennan, S. O., Faed, J. M., & George, P. M. (1996). Fibrinogen Otago: A new mutation causing chain truncation and severe hypofibrinogenaemia. Fibrinolysis, 10(Suppl. 4), (pp. 15-16). doi: 10.1016/S0268-9499(96)80802-2